Subscribe to Money Morning get daily headlines subscribe now! Money Morning Private Briefing today's private briefing Access Your Profit Alerts

Proteon Thera Com ST (NASDAQ: PRTO)

$1.25 USD -$0.05 (-3.85%)
Last Price $1.25
Net Change $-0.05 (-3.85%)
Bid $0
Ask Price $0
Open Price $1.25
Previous Close Price $1.3
High Price $1.3
Low Price $1.2
Number of Trades 268
Volume 124,400
Fifty Two Week High $11.45 (2016-11-29)
Fifty Two Week Low $1.2 (2017-05-26)
Average Daily Volume 162,043
Share Outstanding 16,770 Shares
Total Dividend Payout 0/yr
Dividend Yield 0%
1st Quarter Earnings $ ()
2nd Quarter Earnings $ ()
3nd Quarter Earnings $ ()
4th Quarter Earnings $ ()
PE Ratio $0
EPS Growth $5.91
Recent Earnings $
Annual EPS $-1.72
Last Quarter EPS $
Market Capitalization $0.02B
Insider Shareholders % 0.454%
Annual Revenue $0B
No. Shares Outstanding 16,770
Inst. Shareholder % 43%
Annual Net Income $-0.03B
TTM Net Profit Margin $0
1-Year Return -80.83%
3-Year Return -87.54%
5-Year Return -87.54%
5-Year Revenue Growth 0%
5-Year Earnings Growth 0%
5-Year Dividend Growth 0%
Annual Dividend $0
Annual Dividend Yield 0%
Change in EPS YTD 5.91%
Dividends per Share $
Stock Split Ratio
Beta 1.6
Proteon Therapeutics Inc. is a biopharmaceutical company. The Company is developing pharmaceuticals to address the medical needs of patients with kidney and vascular diseases. It is developing PRT-201, a recombinant human elastase, applied in a single treatment to the external surface of arteries and veins during an open surgical procedure or an endovascular intervention. Proteon Therapeutics Inc. is headquartered in Waltham, Mass.

PRTO News & Stock Updates